The case for entrepreneurship in R&D in the pharmaceutical industry

被引：0
|
作者：
Frank L. Douglas
V. K. Narayanan
Lesa Mitchell
Robert E. Litan
机构：
[1] Frank L. Douglas,
[2] Lesa Mitchell and Robert E. Litan are at the Ewing Marion Kauffman Foundation,undefined
[3] Kansas City,undefined
[4] Missouri,undefined
[5] USA.,undefined
[6] Frank L. Douglas is also at the Austen BioInnovation Institute,undefined
[7] Akron,undefined
[8] Ohio,undefined
[9] USA.,undefined
[10] V. K. Narayanan is at the Center for Research Excellence,undefined
[11] LeBow College of Business,undefined
[12] Drexel University,undefined
[13] Philadelphia,undefined
[14] Pennsylvania,undefined
[15] USA.,undefined
来源：
Nature Reviews Drug Discovery | 2010年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A lack of entrepreneurial behaviour has often been identified as a contributor to the decline in the research and development (R&D) productivity of the pharmaceutical industry. Douglas and colleagues present an assessment of entrepreneurship in the industry, based on interviews with 26 former and current leaders of R&D departments at pharmaceutical and biotechnology companies, highlighting factors that could be important in promoting entrepreneurial behaviour and revitalizing R&D productivity.
引用
收藏
页码：683 / 689
页数：6
相关论文
共 50 条
12345